The Current Ratio as of September 2024 (TTM) for Vir Biotechnology, Inc. (VIR) is 12.51

According to Vir Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 12.51. This represents a change of 10.73% compared to the average of 11.29 of the last 4 quarters.

Vir Biotechnology, Inc. (VIR) Historical Current Ratio (quarterly & annually)

How has VIR Current Ratio performed in the past?

The mean historical Current Ratio of Vir Biotechnology, Inc. over the last ten years is 7.37. The current 12.51 Current Ratio has changed 16.87% with respect to the historical average. Over the past ten years (40 quarters), VIR's Current Ratio was at its highest in in the March 2024 quarter at 12.90. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Vir Biotechnology, Inc. (VIR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vir Biotechnology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vir Biotechnology, Inc. (VIR) Average Current Ratio

How has VIR Current Ratio performed in the past?

The current Current Ratio of Vir Biotechnology, Inc. (VIR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vir Biotechnology, Inc. (VIR) Current Ratio vs. Peers

How is VIR’s Current Ratio compared to its peers?

Vir Biotechnology, Inc.’s Current Ratio is greater than CureVac N.V. (2.29), greater than Reata Pharmaceuticals, Inc. (3.21), greater than Krystal Biotech, Inc. (9.50), greater than Propanc Biopharma, Inc. (0.00), less than IVERIC bio, Inc. (15.53), greater than Blueprint Medicines Corporation (3.71), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than Karuna Therapeutics, Inc. (19.31), greater than Day One Biopharmaceuticals, Inc. (4.09), less than Viking Therapeutics, Inc. (37.69), greater than Intercept Pharmaceuticals, Inc. (4.22), less than Terns Pharmaceuticals, Inc. (21.02), less than Akero Therapeutics, Inc. (24.89), greater than PTC Therapeutics, Inc. (2.23), greater than Madrigal Pharmaceuticals, Inc. (8.72),

Build a custom stock screener for Vir Biotechnology, Inc. (VIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vir Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vir Biotechnology, Inc. (VIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vir Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.